India's First MRNA COVID Vaccine Gets DCGI Nod For Phase 2/3 Trials
[email protected]07 Oct, 2021News
?The mRNA-based vaccine has been developed in partnership with Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC). ?Gennova Biopharmaceuticals Ltd., which is a Pune-based biotechnology company, had submitted the interim clinical data of the Phase I study to the Central Drugs Standard Control Organisation (CDSCO) and the Centre's National Regulatory Authority (NRA).
Related Bookmarks
- Emcure Pharmaceuticals Files Draft IPO Papers With SEBI; Plans To Raise Over Rs 1,100 Crore
- Emcure Pharma Files For ?4,500 Crore IPO
- Emcure Pharma Files Draft Paper For Rs 5,000 Cr IPO
- Bain Capital-Backed Emcure Pharmaceuticals Files DRHP For IPO With Sebi
- Wholesale DID
- Emcure Pharmaceuticals Files Draft Paper For Rs 4,500-Rs 5000 Crore IPO
- Cost-effective Abstract Writing outsourcing services
- Indian Air Force Day 2021: Know How IAF Is Celebrating Its 89th Anniversary
- The TEAM Companies Form Strategic Alliance with Peach
- DIDWW & Daktela team up for extended contact center reach
Recent Profiles
Fb88
Vn88
Sunwin
Pinnacle Earthworks
Unify Abroad
Woodstock Dumpster Rental Group
Vape Shop Dubai
Hitclub
Fabio Hüther
Nicole Reyes